MARSHALL WACE, LLP

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1318757 LONDON, X0

Position in COLL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$9,171,377

-$15,591,835 QoQ

Shares Held

253,353

-66.2% QoQ

Ownership

0.778%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#32

of 280 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. COLL ranks #13 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HIMS	Hims & Hers Health, Inc.	4,217,767	$146,229,981
2	ELAN	Elanco Animal Health Inc	4,432,350	$109,080,132
3	LNTH	Lantheus Holdings, Inc.	773,978	$85,865,119
4	ALKS	Alkermes plc.	969,954	$50,825,589
5	NBIX	Neurocrine Biosciences Inc	270,754	$45,632,878
6	RDY	Dr Reddys Laboratories Ltd	2,025,356	$29,347,408
7	AMPH	Amphastar Pharmaceuticals, Inc.	1,066,322	$21,518,377
8	ZTS	Zoetis Inc.	257,470	$18,501,794

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,171,377	253,353	-66.2%	Shares	Other	2026-08-13
2026-03-31	$24,763,212	748,812	+52.1%	Shares	Other	2026-05-15
2025-12-31	$22,796,266	492,360	+76.5%	Shares	Other	2026-02-13
2025-09-30	$9,762,664	279,013	+104.1%	Shares	Other	2025-11-13
2025-06-30	$4,042,839	136,721	+92.7%	Shares	Other	2025-08-13
2024-06-30	$2,285,040	70,964	-47.8%	Shares	Other	2024-08-14
2023-12-31	$4,187,588	136,049	-64.8%	Shares	Other	2024-02-14
2023-09-30	$8,633,715	386,296	-21.9%	Shares	Other	2023-11-14
2023-06-30	$10,626,289	494,476	-14.7%	Shares	Other	2023-08-14
2023-03-31	$13,912,064	579,911	+88.9%	Shares	Other	2023-05-15
2022-12-31	$7,123,095	307,030	+668.2%	Shares	Other	2023-02-14
2022-09-30	$640,239	39,965	+241.1%	Shares	Other	2022-11-14
2021-06-30	$277,013	11,718	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.